Bimekizumab use for 4 years among patients with plaque psoriasis is associated with sustained efficacy outcomes and no new safety signals.

For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers in blood, characterized by high-sensitivity C-reactive protein, despite ...

She was diagnosed with alopecia areata, an autoimmune condition that disrupts regular hair growth, at just 18 months old and ...

Dr. Orbai has observed that the incidence of thyroid disease is higher in women who also have another ... who have the most common type of psoriasis, plaque psoriasis, there is not a clear ...

Improved clinical efficacy measures and biomarkers in patients with mild-to-moderated active plaque psoriasis. Weisel et al 48 Quarterly subcutaneous administration of canakinumab decreased hsCRP ...

The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

The programme comprises two Phase III trials, ONWARD1 and ONWARD2, and an optional long-term extension trial, ONWARD3.

These features characterize psoriasis on light skin tones. A psoriasis plaque on dark skin tones can vary in color, ranging from light to dark brown, purple, or gray. Occasionally, skin discoloration ...

You may face a higher risk of developing a Candida fungus infection if you have psoriasis. This can make ... An estimated 3 of 4 women are likely to experience a vaginal yeast infection at least ...

Such forward-looking statements include, but are not limited to, statements regarding the potential real-world use results of ZORYVE foam and the potential for ZORYVE to advance the standard of care ...

Additionally, some infections may exacerbate or trigger psoriasis, such as strep throat. Regardless of whether you are on a biologic or immunosuppressive medication for psoriasis, it’s essential ...